The COPE Study: Pilot Intervention to Improve Symptom Self-management and Coping in Adults With Post COVID-19
NCT05658536 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51
Last updated 2024-03-29
Summary
This project is a randomized controlled pilot trial using mixed methods to examine the feasibility, acceptability, and initial effects of a telemedicine group-based intervention designed to improve symptom management and coping in adults with Post-COVID.
Conditions
- Post COVID-19 Condition
- Post-COVID-19 Syndrome
Interventions
- BEHAVIORAL
-
6-Week Self-Management Group
The goal of the 6-session group-based intervention for patients with Post-COVID is to teach patients behavioral strategies known to be helpful in managing several common Post-COVID symptoms, including fatigue, memory and attention issues, poor sleep, breathlessness, coping with anxiety and uncertainty, and stress management. It is currently available to patients who are seen in the Post-COVID-19 Rehabilitation and Recovery Clinic at UW and the Post-COVID-19 Clinic in VAPSHCS Rehabilitation Care Services.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Tracy Herring, PhD · University of Washington
-
Lindsey Knowles, PhD · University of Washington
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-18
- Primary Completion
- 2024-01-30
- Completion
- 2024-01-30
Countries
- United States
Study Locations
More Related Trials
-
Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
NCT06160128 ·Status: RECRUITING
-
Study of Oral High/Low-dose Cepharanthine Compared With Placebo in Non Hospitalized Adults With COVID-19
NCT05398705 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of Efficacy and Safety of Oral Drug in Adult Patients With COVID-19
NCT05365321 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)
NCT04328961 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients
NCT04734873 ·Status: TERMINATED ·Phase: PHASE3
-
Home Usability Study of the SARS-CoV-2 (COVID-19) Test
NCT04395391 ·Status: COMPLETED
-
A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid
NCT06234462 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects
NCT04880642 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection
NCT04637828 ·Status: UNKNOWN ·Phase: PHASE2
-
This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)
NCT04593641 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized
NCT05799495 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol
NCT04662086 ·Status: COMPLETED ·Phase: PHASE2
-
Saved From COVID-19 - Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID
NCT04349371 ·Status: TERMINATED ·Phase: PHASE2
-
Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19
NCT04784754 ·Status: WITHDRAWN ·Phase: PHASE2
-
Intravenous Infusion of CAP-1002 in Patients With COVID-19
NCT04623671 ·Status: COMPLETED ·Phase: PHASE2
-
Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial
NCT04820751 ·Status: UNKNOWN ·Phase: PHASE3
-
Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting
NCT04303507 ·Status: COMPLETED ·Phase: NA
-
A Real-world Retrospective Study of Disease Outcomes in Non-severe COVID-19 Patient
NCT05489874 ·Status: UNKNOWN
-
Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation
NCT04356495 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Protective Effect of Mask Wearing Against Respiratory Tract Infections
NCT05690516 ·Status: COMPLETED ·Phase: NA
-
An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients
NCT04471051 ·Status: COMPLETED
-
Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease
NCT04405999 ·Status: COMPLETED ·Phase: PHASE4
-
PEP Flute-selfcare in COVID-19
NCT04530435 ·Status: COMPLETED ·Phase: NA
-
Surveillance of Individuals Following SARS-CoV-2 Infection
NCT04383444 ·Status: COMPLETED
-
Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.
NCT05785390 ·Status: TERMINATED ·Phase: PHASE2